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Abstract
Background: Schwann cells (SC) which are myelin-forming cells in peripheral nervous system are
very useful for the treatment of diseases of peripheral nervous system and central nervous system.
However, it is difficult to obtain sufficient large number of SC for clinical use, so alternative cell
systems are desired.
Results: Using a procedure similar to the one used for propagation of neural stem cells, we could
induce rat adipose-derived stem cells (ADSC) into floating neurospheres. In addition to being able
to differentiate into neuronal- and glial-like cells, neurospheres could be induced to differentiate
into SC-like cells. SC-like cells were bi- or tri-polar in shape and immunopositive for nestin and SC
markers p75, GFAP and S-100, identical to genuine SC. We also found that SC-like cells could
induce the differentiation of SH-SY5Y neuroblastoma cells efficiently, perhaps through secretion of
soluble substances. We showed further that SC-like cells could form myelin structures with PC12
cell neurites in vitro.
Conclusion: These findings indicated that ADSC could differentiate into SC-like cells in terms of
morphology, phenotype and functional capacities. SC-like cells induced from ADSC may be useful
for the treatment of neurological diseases.
Background
Schwann cells (SC) play a central role in the regeneration
of peripheral nerve, and are essential for peripheral nerve
development [1]. It is recognized that SC can provide an
option for the treatment of diseases of central nervous sys-
tem (CNS), such as multiple sclerosis [2]. In CNS, SC
transplantation can promote the re-growth of nerve fibres
despite unfavorable environment [3]; SC can remyelinate
demyelinated axons of CNS [4]. SC can clear debris by
phagocytosis and break down devastated myelin [5],
which can provide an important prerequisite for success-
ful remyelination in demyelinating diseases of CNS [6].
However, it is difficult to obtain sufficient large number of
SC for clinical use, so alternative cell systems are desired.
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Bone marrow stromal cells (MSCs) can be obtained easily,
can be expanded in culture conditions for autologous
transplantation, and MSCs can transdifferentiate along a
SC lineage in vitro [7] and in vivo [8]. So, MSCs may be
one of alternative cell systems for SC. However, for clini-
cal use, MSCs have presented problems: MSCs procure-
ment procedures are painful and frequently require
general or spinal anesthesia and may yield low number of
MSCs upon harvest [9]. For these reasons, many research-
ers begin to investigate alternative sources for MSCs.
Adipose tissue, like bone marrow, is derived from embry-
onic mesoderm. Cells isolated from adipose tissue,
termed adipose-derived stem cells (ADSC), are self-
renewal and can differentiate along several mesenchymal
tissue lineages, including adipocytes, osteoblasts, myo-
cytes, chondrocytes, endothelial cells and cardiomyocytes
[10,11]. ADSC may also be induced into neurospheres
[12,13] and neuronal-like cells in vitro [14], and intracer-
ebral transplantation of human ADSC can improve the
neurological deficits after cerebral ischemia in rats [15].
Subcutaneous adipose tissue is abundant, readily accessi-
ble, and relatively expendable. Liposuction is a common
surgical procedure and it is safe, and a large number of
cells can be obtained with minimal risk [16]. ADSC may
be an ideal alternative cell source for SC. However, it is not
known up to now whether ADSC could be induced into
SC.
In this study, we found that rat ADSC could be converted
into neurospheres, and these neurospheres could be
induced into SC-like cells. SC-like cells could induce the
differentiation of SH-SY5Y neuroblastoma cells effi-
ciently, and could form myelin structures with neuronal
neurites.
Results
Rat ADSC characterization
Within 3–5 passages after initial plating of the primary
culture, rat ADSC appeared to be a mono-layer of large
and flat cells (Figure 1A). Confluent rat ADSC showed a
spindle-shaped, fibroblastic morphology. Rat ADSC
could be passaged for at least 10 times, with a doubling
time of 2.8 days. Flow cytometry analysis of rat ADSC
within 3–5 passages showed that rat ADSC were CD29
and CD44 positive, but CD31, CD106, CD184, CD34 and
CD45 negative (Figure 2). Rat ADSC did not spontane-
ously differentiate during culture expansion. When cul-
tured in lineage-specific differentiation culture medium,
rat ADSC within 3–5 passages could undergo osteogenic
(Figure 1B) and adipogenic (Figure 1C) differentiation.
About 5 ± 3% of rat ADSC within 3–5 passages were nes-
tin positive (Figure 1D), whereas almost all of rat ADSC
expressed mesodermal marker fibronectin (Figure 1E).
Markers of neuronal or glial cell types, such as beta-tubu-
lin III, GFAP, p75 and S-100 could not be detected in rat
ADSC (not shown).
Conversion of rat ADSC into neurospheres
ADSC can be converted into neurospheres using a proce-
dure similar to the one used for the propagation of neural
stem cells [12,13]. Rat ADSC within 3–5 passages were
detached, and re-plated in serum-free DMEM/F12
medium supplemented with epidermal growth factor
(EGF) and basic fribroblast growth factor (bFGF). Few
cells adhered to the surface of flasks. A lot of small spheres
of floating cells appeared after 2–4 days in conversion cul-
ture, and these spheres could proliferate in vitro for up to
2 months (Figure 3A). Neurospheres could be passaged
every 7–10 days, with an estimated doubling time of 3
days. More than 90% of rat ADSC converted into neuro-
spheres. About 85 ± 7% of neurosphere cells expressed
nestin (Figure 3B), whereas only a small part of neuro-
sphere cells expressed fibronectin (Figure 3C). The expres-
sion of beta-tubulin III, GFAP, S-100 and p75 were
undetectable in neurosphere cells (not shown). As soon as
the neurospheres were plated in poly-L-lysine-coated
chamber slides in Neurobasal® medium supplemented
with only B27, the neurospheres began to spread across
the growth surface (Figure 3D). Ten days after differentia-
tion, a lot of differentiated neurosphere cells would gain a
neuronal morphology, and the cell processes would grow
much longer (Figure 3E). Immunostaining showed that
29 ± 6% and 22 ± 5% of the differentiated neurosphere
cells were positive for neuronal marker beta-tubulin III
(Figure 3F) and glial marker GFAP (Figure 3G), respec-
tively.
Neurospheres could be induced to differentiate along a SC 
lineage
Triturated neurospheres were re-plated in poly-L-lysine-
coated six-well chamber slides in SC differentiation
medium which contained all-trans-retinoic acid (RA), for-
skolin (FSK), platelet-derived growth factor (PDGF-BB)
and Heregulin. Some bi-polar, spindle-like cells began to
appear at 12 hours after differentiation, and almost all of
cells were bi- or tri-polar, spindle-like at 24 and 48 hours
after differentiation (Figure 4A), similar to the cultured
immature genuine SC. About 60 hours after differentia-
tion, a lot of differentiated neurosphere cells (i.e., SC-like
cells) would aggregate and float, obviously dead. Forty-
eight hours after differentiation, we replaced the SC differ-
entiation medium with DMEM plus 10% FBS, then we
observed that SC-like cells could survive, proliferate to a
higher cell density (Figure 4B) and could be passaged at
least for 1 to 2 times without changing their morphology
and phenotype. Forty eight hours after differentiation, we
detected the expression of nestin which is normally
expressed in genuine SC [17] and SC markers p75, S-100
and GFAP [1,18] to evaluate the nature of SC-like cells.BMC Neuroscience 2008, 9:21 http://www.biomedcentral.com/1471-2202/9/21
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Immunostaining showed that almost all of the SC-like
cells expressed nestin (Figure 4C), GFAP (Figure 4D) and
S-100 (Figure 4E), and 35 ± 5% of the SC-like cells
expressed p75 (Figure 4F).
SC-like cells could induce the differentiation of SH-SY5Y 
cells efficiently
We used SH-SY5Y cells to evaluate whether SC-like cells
could secrete soluble factors since genuine SC can induce
the differentiation of SH-SY5Y neuroblastoma cells effi-
ciently through production of soluble factors [19].
After being cultured in the conditioned medium (CM)
collected from SC-like cells for 3 days, part of SH-SY5Y
cells showed neurite outgrowth under phase contrast (Fig-
ure 5B), whereas there was no neurite outgrowth in con-
trol group (Figure 5A). Immunofluorescent staining
confirmed that 31 ± 6% of SH-SH5Y cells expressed neu-
ronal marker beta-tubulin III after being cultured in CM
from SC-like cells for 3 days (Figure 5D); in contrast, beta-
tubulin III positive cells were very rare or no in control
group (Figure 5C).
SC-like cells could form myelin structures with neuronal 
neurites
PC12 cells (rat pheochromocytoma cell line) were used to
assess the myelinating capacity of SC-like cells since genu-
ine SC can induce the differentiation of PC12 cells and
Rat ADSC Characterization Figure 1
Rat ADSC Characterization. Rat ADSC were passaged for 3–5 times after initial plating of the primary culture. A: Under 
phase contrast, cultured rat ADSC are spindle-shaped. B, C: Rat ADSC could undergo multi-lineage differentiation, including 
osteogenesis (B) and adipogenesis (C), as visualized by staining with Alizarin Red S and Oil-Red O, respectively. D, E: Immuno-
cytochemistry of rat ADSC within 3–5 passages. About 5 ± 3% of rat ADSC express neural stem cell marker nestin (D), 
whereas almost all of the rat ADSC express mesodermal marker fibronectin (E). Nuclei are labeled with DAPI (blue). Bar, A: 
50 μm; B-E: 50 μm.BMC Neuroscience 2008, 9:21 http://www.biomedcentral.com/1471-2202/9/21
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form myelin structures with PC12 cell neurites [20]. PC12
cells had none or short processes. Most of PC12 cells
stretched out noticeable processes after being cultured in
DMEM plus 10% FBS for a few passages. Addition of SC-
like cells induced a rapid neuronal-like differentiation of
PC12 cells, and extension of neurites could be observed.
Electron microscopy results showed that after 14 days,
PC12/SC-like cell co-culture formed myelin structures,
and a lot of myelin structures were compact (Figure 6A).
The myelin structures were composed of multiple layers of
membranes (Figure 6B). Rat ADSC could not form myelin
structures with PC12 cell neurites (not shown).
Discussion
Our results demonstrate that rat ADSC could be converted
into neurospheres using a procedure similar to the one
used for propagation of genuine neural stem cells. In addi-
tion to generating neuronal- and glial-like cells, neuro-
sphere cells from rat ADSC could differentiate into SC-like
cells. We showed further that SC-like cells were functional
since these cells could secrete soluble factors and form
myelin structures with neuronal neurites. Functional
properties, especially formation of myelin structures with
neuronal neurites, further indicated that SC-like cells from
rat ADSC were closely similar to genuine SC.
Primary cultures of adipose tissue are heterogeneous, con-
taining hepatopoietic cells, endothelial cells, smooth
muscle cells and pericytes [9]. However, the number of
these other cells is small, and the frequency of these other
cells will diminish quickly through serial passages [21].
Also, ADSC can differentiate into several mesenchymal
Flow cytometric analysis of rat ADSC Figure 2
Flow cytometric analysis of rat ADSC. Rat ADSC within 3–5 passages were harvested and detected of specific cell surface 
antigens. Cells stained with a FITC-conjugated nonspecific IgG were examined as a control (FITC). Flow cytometric analysis 
shows that rat ADSC do not express CD31, CD106, CD184, CD34 and CD45, but express CD29 and CD44.BMC Neuroscience 2008, 9:21 http://www.biomedcentral.com/1471-2202/9/21
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tissue lineages, including adipocyte and osteoblast. Rat
ADSC within 3–5 passages we used in our experiment
were CD29 and CD44 positive, CD31, CD106, CD184,
CD34 and CD45 negative, and could undergo osteogenic
and adipogenic differentiation. All these characteristics of
rat ADSC in our experiments are consistent with previous
reports [10].
Although ADSC and MSCs share many common biologi-
cal characteristics, the two populations are not identical
[12]. Immunocytochemical analysis shows that surface
epitope profiles of the two populations are different [10];
although it is well established that both MSCs and ADSC
can undergo chondrogenic differentiation [22], Kang et al
show that ADSC but not MSCs could undergo chondro-
genic differentiation under the conditions used in their
study; ADSC may have significantly higher neural differ-
Characterization of neurospheres converted from rat ADSC Figure 3
Characterization of neurospheres converted from rat ADSC. A: Under phase contrast, neurospheres grow as spheres 
of floating cells. B, C: Immunocytochemistry of neurospheres. Neurospheres were triturated before being examined. About 85 
± 7% of the neurosphere cells express nestin (B), whereas only a small part of neurosphere cells express fibronectin (C). D-G: 
Neurosphere cells can differentiate into neural cells. Neurospheres were cultured and maintained for 10 days in Neurobasal® 
medium supplemented only with B27 supplement on poly-L-lysine-coated substrate. Neurospheres attach to the bottom of the 
culture dish and protrude cell processes (D), some cells gain a neuronal morphology and the processes grow much longer 10 
days after plating (E); Immunocytochemistry shows that part of the differentiated neurosphere cells express neuronal marker 
beta-tubulin III (F) and glial marker GFAP (G) 10 days after plating. Nuclei are labeled with DAPI (blue). Bar, 50 μm.BMC Neuroscience 2008, 9:21 http://www.biomedcentral.com/1471-2202/9/21
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entiation capacities than those of MSCs [12]; the distinc-
tions between the two populations may also extend down
to the gene level [10,12]. Although MSCs can be induced
to differentiate along SC lineage [7], the differences
between the two populations mentioned above suggest
that whether ADSC could be induced to differentiate
along SC lineage needs to be confirmed.
Some recent studies show that neural crest stem cells can
be harvested by means of neurosphere method from vari-
ous seemingly "mesodermal" tissues of adult animals,
such as heart [23] and hair follicular dermal papilla [24].
Kang et al. show that ADSC can be converted into neuro-
spheres [12], and a preliminary report further suggests
that neurosphere cells derived from ADSC may have neu-
ral crest-like properties [13]. In our experiment, since neu-
rospheres converted from rat ADSC could differentiate
into SC-like cells which belong to peripheral nervous sys-
tem, these neurospheres should have the characteristics of
peripheral nervous system.
Recently, nestin expression has also been observed in
myogenic cells, hepatic cells and endothelial cells, which
indicates that nestin may not be used as a specific marker
for neural stem cells. However, in our experiment, neuro-
sphere cells from rat ADSC can be induced into neuronal-
and glial-like cells, which strongly indicates that neuro-
sphere cells derived from rat ADSC have neural stem cell-
Neurosphere cells could differentiate into SC-like cells Figure 4
Neurosphere cells could differentiate into SC-like cells. Neurosphere cells were cultured for 48 hours on poly-L-
lysine-coated six-well chamber slides in SC differentiation medium. A, B: Under phase contrast, most of the differentiated neu-
rosphere cells (SC-like cells) are bi- or tri-polar, spindle-like 48 hours after differentiation (A), and these spindle-like cells can 
proliferate to a higher cell density when the SC differentiation medium was replaced with DMEM plus 10% FBS 48 hours after 
differentiation (B). C-F: Immunocytochemistry of SC-like cells. Almost all the SC-like cells express nestin (C), GFAP (D) and S-
100 (E) in the cytoplasm, and 35 ± 5% of the SC-like cells express p75 in the cytomembrane (F). Nuclei are labeled with DAPI 
(blue). Bar, 50 μm.BMC Neuroscience 2008, 9:21 http://www.biomedcentral.com/1471-2202/9/21
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like properties. Hermann et al suggest that neural stem
cell-like cells converted from MSCs are real neural stem
cells [25]. The immature neural stem cells would be more
suitable for the treatment of neurodegenerative diseases
than fully differentiated neural cells, because fully differ-
entiated neurons can not survive detachment and subse-
quent transplantation procedures [26].
Neural stem cells from CNS can be maintained in an
undifferentiated status by bFGF and EGF [27,28]. When
exposed to RA, neural stem cells will exit from cell cycle
and differentiate into nerve cells [29]. In our experiment,
neurosphere cells will differentiate in the presence of RA
and in the absence of EGF and bFGF.
FSK can elevate the level of intracellular cyclic adenosine
monophosphate (cAMP) and cAMP signal may be an
intracellular signal during several different stages of SC
development. In cultured SC, cAMP elevation can mimick
SC responses in the presence of axons during myelination
in vivo [30]. In addititon, FSK can enhance the responsive-
ness of SC to SC mitogens, such as PDGF-BB and glial
growth factor [31]. PDGF-BB can induce SC proliferation
in the presence of serum and FSK [32]. Heregulin is a sub-
SC-like cells can induce the differentiation of SH-SY5Y neuroblastoma cells Figure 5
SC-like cells can induce the differentiation of SH-SY5Y neuroblastoma cells. SH-SY5Y cells were cultured in DMEM 
plus 2% FBS (control group) or SC-like cell-CM for 3 days. A, B: Under phase contrast, neurite outgrowth is minimal-to-no in 
control group (A), whereas many of the SH-SY5Y cells extend long neurites in SC-like cell-CM group (B). C and D: Immunocy-
tochemistry of beta-tubulin III in control group and SC-like cell-CM group. Few or no SH-SY5Y cells are beta-tubulin III positive 
in control group (C), whereas 31 ± 6% of the SH-SY5Y cells are beta-tubulin III positive in SC-like cell-CM group (D). Nuclei 
are labeled with DAPI (blue). Bar, 50 μm.
SC-like cells could form myelin structures with neuronal neu- rites Figure 6
SC-like cells could form myelin structures with neu-
ronal neurites. PC12 cells and SC-like cells from rat ADSC 
were co-cultured for 14 days. Electron micrographs show 
that compact myelin structures could be seen (A), and myelin 
structures are composed of multiple layers of membranes 
(B). A, ×21000; B, ×63000.BMC Neuroscience 2008, 9:21 http://www.biomedcentral.com/1471-2202/9/21
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type of neuregulin-1 and neuregulin-1 is now regarded as
the pivotal signal that controls SC at every stage of the lin-
eage [33]. Neuregulin-1 type II, also known as glial growth
factor, can induce instructively cultured neural crest cells
into SC [34]. In the presence of Heregulin (neuregulin-1
type I), MSCs can be induced into SC-like cells [35]. A
mixture of cytokines mentioned above may synergize to
induce neurosphere cells into SC-like cells.
SC can produce a number of neurotrophic factors, and a
combination of these and other SC-derived soluble factors
have been referred to as 'anti-neuroblastoma' agents [36].
Pigment epithelium-derived factor is now regarded as the
key factor responsible for SC's ability to induce the differ-
entiation of SH-SY5Y cells [19]. It is likely that SC-like
cells from rat ADSC in our experiment produced at least
some 'anti-neuroblastoma' agents produced by genuine
SC since SC-like cells could induce the differentiation of
SH-SY5Y cells efficiently. SC-like cells induced from MSCs
can cause neurite growth of dorsal root ganglion neurons
in vitro [7], which supports that SC-like cells from rat
ADSC may produce some soluble factors. These SC-
derived factors, such as pigment epithelium-derived fac-
tor, can promote survival and neurite outgrowth of neu-
rons. SC-like cells from ADSC may be useful for the
treatment of diseases in peripheral nervous system (e.g.,
nerve injuries) and CNS (e.g., multiple sclerosis).
Conclusion
Our research indicated that ADSC could differentiate into
SC-like cells in terms of morphology, phenotype and
functional capacities. SC-like cells induced from ADSC
may be useful for the treatment of neurological diseases.
Methods
Cell culture
The local ethics committee approved the animal experi-
mentation protocols and all animal experiments were per-
formed according to Sun Yat-sen university guidelines for
animal care. Four- to 8- week-old, male, Sprague-Dawley
rats were used for the isolation of rat ADSC. Animals were
housed under standard conditions. After sacrifice of the
rats, the inguinal fat pad was harvested, and rat ADSC
were isolated using a published method [14]. Briefly, the
adipose tissue was dissociated mechanically, digested
using collagenase type I (Gibco, Carlsbad, CA, USA). The
suspension was centrifuged to separate the floating adi-
pocytes from the stromal vascular fraction. Then the cells
in the stromal vascular fraction were cultured in Dul-
becco's modified Eagle's medium (DMEM; Gibco) sup-
plemented with 10% fetal bovine serum (FBS; Gibco).
After 24 hours, the non-adherent cells were eliminated by
changing the medium. Rat ADSC were passaged for 3–5
times before being used for the experiments.
SH-SY5Y neuroblastoma cell line and PC12 cells (rat phe-
ochromocytoma cell line) were obtained from the Ameri-
can Tissue Type and Culture. SH-SY5Y cells were cultured
in DMEM plus 10% FBS in 5%CO2 at 37°C. PC12 cells
were cultured in DMEM/F12 (1:1, Gibco) supplemented
with 15% horse serum (Gibco) and 2.5% FBS at 37°C in
5% CO2.
Flow cytometry
Rat ADSC within 3–5 passages after the initial plating of
the primary culture were harvested by trypsinization, then
the cells were fixed in neutralized 2% paraformaldehyde
solution for 30 minutes. The fixed cells were washed twice
with PBS and incubated with antibodies to the following
antigens: CD31, CD106, CD184, CD34, CD45, CD29 and
CD44 (all from Chemicon, Temecula, CA, USA) for 30
minutes. Primary antibodies were directly conjugated
with FITC. For isotype control, nonspecific FITC-conju-
gated IgG was substituted for the primary antibodies [10].
Flow cytometry was performed with a FACscan flow
cytometer (Becton Dickinson, San Jose, CA).
Adipogenic and osteogenic differentiation of rat ADSC
Rat ADSC within 3–5 passages were used to verify the
multi-potential differentiation capacity. Cells were grown
to at least 80% confluence before being cultured in the
induction medium. To induce osteogenic differentiation,
rat ADSC were cultured for three weeks in DMEM supple-
mented with 10% FBS, 0.1 μM dexamethasone, 50 μM
ascorbate-2-phosphate, 10 mM beta-glycerophosphate.
Mineralization of the extracellular matrix was visualized
by staining with Alizarin Red S. To induce adipogenic dif-
ferentiation, rat ADSC were cultured for three weeks in
DMEM supplemented with 10% FBS, 0.5 mM isobutyl-
methylxanthine (IBMX), 1 μM dexamethasone, 10 μM
insulin, 200 μM indomethacin. Adipogenic differentia-
tion was confirmed by staining with Oil-Red O.
Induction of rat ADSC into neurospheres
Rat ADSC within 3–5 passages were induced into neuro-
spheres. In detail, we dissociated rat ADSC (80–90% con-
fluence) with 0.25% trypsin (Gibco) and then plated
them on culture flasks at a concentration of 1–2 × 105/cm2
in DMEM/F12 (1:1) supplemented with 20 ng/ml EGF
(Peprotech, London, UK), 20 ng/ml bFGF (Peprotech)
and B27 (1:50, Gibco) (neurosphere growth medium, NG
medium) at 37°C in 5%CO2 [12,13]. We added fresh NG
medium every 3 to 4 days and changed the medium once
a week. Neurospheres were passaged every 7 to 10 days by
being triturated using a fire-polished Pasteur pipette and
being re-plated in fresh medium. We triturated neuro-
spheres and re-plated them in poly-L-lysine (Sigma, St
Louis, MO, USA)-coated six-well chamber slides for termi-
nal differentiation experiments.BMC Neuroscience 2008, 9:21 http://www.biomedcentral.com/1471-2202/9/21
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Terminal differentiation of neurospheres
To induce neurospheres into neural cells, neruospheres
from rat ADSC were plated in poly-L-lysine-coated six-
well chamber slides and cultured in Neurobasal® medium
(Gibco) supplemented with B27 (1:50) for 10 days. Dur-
ing differentiation, 70% of the medium was replaced
every 4 days [12].
To induce neurospheres into SC-like cells, we triturated
neurospheres and re-plated them in poly-L-lysine-coated
six-well chamber slides at a density of 2.0–2.5 × 105 cells/
cm2. We cultured the cells in NG medium for 6 to 8 hours
first, then we removed the NG medium, and washed the
cells twice with phosphate buffered saline (PBS). Then the
cells were induced to differentiate for 48 hours in DMEM
supplemented with 10% FBS, 0.5 μM RA (Sigma), 5 μM
FSK (Alexis, Lausen, Switzerland), 10 ng/ml PDGF-BB
(Peprotech) and 200 ng/ml Heregulin-beta1 (Peprotech)
(SC differentiation medium). In some experiments, the
SC differentiation medium was replaced with DMEM plus
10% FBS 48 hours after differentiation.
CM preparation
CM was collected from SC-like cells. SC-like cells were
grown to 80% confluence. We aspirated the medium and
rinsed the cells twice with 5 ml of PBS. We then aspirated
the rinse medium and added 4 ml of DMEM supple-
mented with 2% FBS. The cells were cultured at 37°C in
5% CO2. Forty-eight hours later, we harvested and centri-
fuged the medium (1000 g, 5 minutes), and collected the
supernatant as SC-like cell-CM [19].
Assessment of the differentiation of SH-SY5Y cells
We dissociated SH-SY5Y cells, and seeded 1 ml of cell sus-
pensions containing 1.25 × 104 cells/ml in each well of
24-well plates coated with poly-L-lysine. Twenty-four
hours later, we washed SH-SY5Y cells twice with PBS and
cultured the cells for 3 days in the following medium: 1)
DMEM with 2% FBS (control group); 2) SC-like cell-CM
(SC-like cell-CM group). A cell whose neurite length was
longer than 50 μm was regarded as differentiated [19]. We
used antibody against beta-tubulin III protein (Chemi-
con) to confirm the neuronal differentiation of SH-SY5Y
cells.
Immunocytochemistry
We detected the expression of each antigen for 2 to 4 times
in independent experiments. We fixed the cells with 4%
paraformaldehyde, blocked the cells with normal goat
serum. Then anti-nestin (mouse monoclonal, 1:40), anti-
beta-tubulin III (mouse monoclonal, 1:100), anti-glial fil-
ament acidic protein (GFAP; mouse monoclonal, 1:400),
anti-S-100 (mouse monoclonal, 1:100), anti-p75 nerve
growth factor receptor (p75; mouse monoclonal, 1:222)
(all from Chemicon) and anti-fibronectin (mouse mono-
clonal, 1:250; Neomarkers, Fremont, CA, USA) were
added. The primary antibodies were incubated overnight
at 4°C. We used Cy3-conjugated goat anti-mouse anti-
body (Chemicon) as secondary antibody which was incu-
bated at room temperature for 1 hour. Then we used DAPI
(Sigma) to label the nuclei. Primary antibodies were omit-
ted for control. We examined the cells with a fluorescence
microscope (Olympus DP70, Japan).
In vitro myelination assay
Before being used for the co-culture experiment, PC12
cells were cultured in DMEM plus 10% FBS for a few pas-
sages until most of PC12 cells stretched out noticeable
processes [20]. PC12 cells cultured in DMEM plus 10%
FBS for a few passages were dissociated and re-plated at a
density of 500 cells/cm2 in poly-L-lysine coated culture
dishes in DMEM plus 10% FBS. After 12–24 hours, the
medium was removed from PC12 cells, and 500 dissoci-
ated rat ADSC or 500 SC-like cells from rat ADSC were
seeded into each dish, respectively. PC12/SC-like cells and
PC12/rat ADSC were cultured in DMEM plus 10% FBS for
14 days, and the medium was changed every 2–3 days
[20]. After 14 days, the cocultures were fixed in 2% glutar-
aldehyde in sodium cacodylate buffer at 4°C. Following
treatment with 1% osmium tetroxide and 1% uranyl ace-
tate, samples were embedded in epon. Ultra-thin sections
(50–70 nm) were cut and mounted on Formvar-coated
slot grids, and stained for 20 s in 1:1 supersaturated uranyl
acetate in acetone followed by staining in 0.2% lead cit-
rate. For examination a CM10 transmission electron
microscope (Philips, Netherlands) was used. Electron
microscopy was performed at electron microscopy center
of Sun Yat-sen university.
Statistical analysis
We photographed ten random fields per marker. We
counted the number of positively stained cells and the
total cell number as indicated by DAPI nuclear labeling,
respectively. Data are expressed as means ± S.D for all
samples. We used SPSS 11.0 to analyze the data. Statistical
comparisons were made by student t test. We set statistical
significance at p < 0.05 for all the tests performed.
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